Zhang Hui, Yang Qiwen, Liao Kang, Ni Yuxing, Yu Yunsong, Hu Bijie, Sun Ziyong, Huang Wenxiang, Wang Yong, Wu Anhua, Feng Xianju, Luo Yanping, Hu Zhidong, Chu Yunzhuo, Chen Shulan, Cao Bin, Su Jianrong, Gui Bingdong, Duan Qiong, Zhang Shufang, Shao Haifeng, Kong Haishen, Badal Robert E, Xu Yingchun
Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Science, Beijing, China.
First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
Antimicrob Agents Chemother. 2015 Oct 19;60(1):245-51. doi: 10.1128/AAC.00956-15. Print 2016 Jan.
To evaluate the antimicrobial susceptibility of Gram-negative bacilli that caused hospital-acquired and community-acquired intra-abdominal infections (IAIs) in China between 2012 and 2013, we determined the susceptibilities to 12 antimicrobials and the extended-spectrum β-lactamase (ESBL) statuses of 3,540 IAI isolates from seven geographic areas in China in a central laboratory using CLSI broth microdilution and interpretive standards. Most infections were caused by Escherichia coli (46.3%) and Klebsiella pneumoniae (19.7%). Rates of ESBL-producing E. coli (P = 0.031), K. pneumoniae (P = 0.017), and Proteus mirabilis (P = 0.004) were higher in hospital-acquired IAIs than in community-acquired IAIs. Susceptibilities of enterobacteriaceae to ertapenem, amikacin, piperacillin-tazobactam, and imipenem were 71.3% to 100%, 81.3% to 100%, 64.7% to 100%, and 83.1% to 100%, respectively, but imipenem was ineffective against P. mirabilis (<20%). Although most ESBL-positive hospital-acquired isolates were resistant to third- and fourth-generation cephalosporins, the majority were susceptible to cefoxitin (47.9% to 83.9%). Susceptibilities of ESBL-positive isolates to ampicillin-sulbactam (<10%) were low, whereas susceptibilities to ciprofloxacin (0% to 54.6%) and levofloxacin (0% to 63.6%) varied substantially. The prevalences of cephalosporin-susceptible E. coli and K. pneumoniae were higher in the northeastern and southern regions than in the central and eastern regions, reflecting the ESBL-positive rates in these areas, and were lowest in the Jiangsu-Zhejiang (Jiang-Zhe) area where the rates of carbapenem resistance were also highest. Ertapenem, amikacin, piperacillin-tazobactam, and imipenem are the most efficacious antibiotics for treating IAIs in China, especially those caused by E. coli or K. pneumoniae. Resistance to cephalosporins and carbapenems is more common in the Jiang-Zhe area than in other regions in China.
为评估2012年至2013年期间在中国引起医院获得性和社区获得性腹腔内感染(IAIs)的革兰氏阴性杆菌的抗菌药敏性,我们在一个中心实验室使用美国临床和实验室标准协会(CLSI)肉汤微量稀释法及解释标准,测定了来自中国七个地理区域的3540株IAIs分离株对12种抗菌药物的敏感性及超广谱β-内酰胺酶(ESBL)状态。大多数感染由大肠埃希菌(46.3%)和肺炎克雷伯菌(19.7%)引起。医院获得性IAIs中产ESBL的大肠埃希菌(P = 0.031)、肺炎克雷伯菌(P = 0.017)和奇异变形杆菌(P = 0.004)的比例高于社区获得性IAIs。肠杆菌科细菌对厄他培南、阿米卡星、哌拉西林-他唑巴坦和亚胺培南的敏感性分别为71.3%至100%、81.3%至100%、64.7%至100%和83.1%至100%,但亚胺培南对奇异变形杆菌无效(<20%)。尽管大多数产ESBL的医院获得性分离株对第三代和第四代头孢菌素耐药,但大多数对头孢西丁敏感(47.9%至83.9%)。产ESBL分离株对氨苄西林-舒巴坦的敏感性较低(<10%),而对环丙沙星(0%至54.6%)和左氧氟沙星(0%至63.6%)的敏感性差异很大。头孢菌素敏感的大肠埃希菌和肺炎克雷伯菌在东北地区和南部地区的比例高于中部和东部地区,这反映了这些地区的ESBL阳性率,在江苏-浙江(江浙)地区最低,该地区碳青霉烯类耐药率也最高。厄他培南、阿米卡星、哌拉西林-他唑巴坦和亚胺培南是治疗中国IAIs最有效的抗生素,尤其是由大肠埃希菌或肺炎克雷伯菌引起的感染。在中国,江浙地区对头孢菌素和碳青霉烯类的耐药比其他地区更常见。